Terpenoid Therapeutics terpenoid.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Terpenoid Therapeutics is a drug discovery and development company focused on treatments for cancer. The company are developing a portfolio of small molecule- based compounds primarily for treatment of prostate, brease, brain, lung and colon cancers.

Terpenoid Therapeutics is a drug discovery and development company focused on treatments for cancer. The company are developing a portfolio of small molecule- based compounds primarily for treatment of prostate, brease, brain, lung and colon cancers.

Company (Alive / Active)

Phone: 319-665-2005

Fax:

2500 Crosspark Road, E132
BioVentures Center
Iowa City, 52242
Iowa, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Terpenoid Therapeutics $1.3M Mar 4, 2016
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Terpenoid Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Knopp Biosciences

Pittsburgh, Pennsylvania, United States
Alive / ActiveKnopp Biosciences is a drug discovery and development company focused on delivering treatments for unmet medical needs through experience and partnership. The company's clinical and preclinical programs focus on mechanisms of mitochondrial energetics and its lead compound, dexpramipexole, is currently in Phase 3 clinical development for amyotrophic lateral sclerosis. Additional programs include dexpramipexole combination therapy for Parkinson's disease and the discovery of ion channel modulators...Show allLogin to see details

Echelon Biosciences

Salt Lake City, Utah, United States
Alive / ActiveEchelon Biosciences is a company that received a SBIR Phase I grant for a project entitled: Near Infrared Substrates for Imaging Autotaxin Activity In Vivo. Their project aims to synthesize ATXRed, an in vivo imaging agent that is specifically activated by the enzymatic activity of autotaxin. Autotaxin is an extracellular enzyme that generates the phospholipid growth factor lysophophatidic acid (LPA). LPA is involved in a variety of biological functions, such as angiogenesis, wound healing, brai...Show allLogin to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)